Study Drug News Today

brooding office for the left at the high court, president biden took a swipe at the justices while in madrid at the nato summit. >> the one thing that has been destabilizing is the outrageous behavior of the supreme court of the united states. >> mr. bidens remarks aimed at the government came shortly be before the final two firms were released. pushing back to the definitive state held 6-3 that the epa went beyond its power to practice sweeping plan to curb carbon emissions. justice r...

26.03.2024 - TORONTO, ON / ACCESSWIRE / March 26, 2024 / Theralase Technologies Inc. (Theralase or the Company) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic ... Seite 1

Theralase(R) to Host Advisory Board Meetings at Canadian Urological ...

Abstract 1574238: INTRATUMORAL INT230-6 ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY AND IMMUNE ACTIVATION IN ADULTS WITH...

This study reports the results of 3 randomized, double-masked, placebo-controlled substudies of abatacept, cenicriviroc, and infliximab plus standard care for C

In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase®

TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development

Theralase Provides Update on Phase II Bladder Cancer Study

The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in the prevention of stroke events in pa

Investegate announcements from MGC Pharmaceuticals, CogniCann� Phase II Clinical Trial Results